Nasikarn Angkasekwinai
Overview
Explore the profile of Nasikarn Angkasekwinai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Praneechit H, Thiemmeca S, Prayongkul D, Kongmanas K, Mairiang D, Punyadee N, et al.
mBio
. 2024 Nov;
15(12):e0150524.
PMID: 39540772
Dengue virus (DENV) infection poses a significant global health threat, yet our understanding of its immunopathogenesis remains incomplete due to limitations of existing models. Here, we establish an whole-blood model...
2.
Songjaeng A, Chin-Inmanu K, Proykhunthod P, Poraha R, Sayboonruan P, Prayongkul D, et al.
Microbiol Resour Announc
. 2024 Oct;
13(12):e0052224.
PMID: 39470230
Here, we present the genome sequences of dengue viruses (DENV) isolated from adult patients in Thailand during 2016-2017: DENV2 (412749), DENV3 (416384), and DENV4 (416709). These sequences provide valuable genetic...
3.
Ding J, Mairiang D, Prayongkul D, Puttikhunt C, Noisakran S, Kaewjiw N, et al.
CPT Pharmacometrics Syst Pharmacol
. 2024 Sep;
13(12):2196-2209.
PMID: 39308445
The increased incidence of dengue poses a substantially global public health challenge. There are no approved antiviral drugs to treat dengue infections. Ivermectin, an old anti-parasitic drug, had no effect...
4.
Salvadori N, Jourdain G, Krittayaphong R, Siripongboonsitti T, Kongsaengdao S, Atipornwanich K, et al.
Int J Infect Dis
. 2024 Apr;
143:107021.
PMID: 38561040
Objectives: Evaluate and compare the efficacy and safety of molnupiravir and favipiravir in outpatients with mild to moderate COVID-19 and at risk of severe COVID-19. Methods: In an open-label, parallel-group,...
5.
Angkasekwinai N, Suputtamongkol Y, Tantibhedhyangkul W, Onlamoon N, Phoompoung P, Pithukpakorn M, et al.
Clin Infect Dis
. 2023 Nov;
78(4):1033-1042.
PMID: 37947190
Background: Currently, there is no effective treatment for adult-onset immunodeficiency (AOID) syndrome with anti-interferon-gamma autoantibodies (anti-IFN-γ-auto-Abs). This study aimed to investigate the effectiveness of bortezomib (BTZ) for decreasing anti-IFN-γ-auto-Abs. Methods:...
6.
Pattanaprichakul P, Leeyaphan C, Angkasekwinai N, Bunyaratavej S, Senawong S, Sereeaphinan C, et al.
Int J Dermatol
. 2023 Oct;
62(12):1506-1510.
PMID: 37828737
Background: Cutaneous findings in adult-onset immunodeficiency due to anti-interferon gamma autoantibodies (anti-IFN-γ autoAbs) are common. Currently, data on this topic are scarce. Methods: We retrospectively reviewed medical records of 202...
7.
Angkasekwinai N, Niyomnaitham S, Sewatanon J, Phumiamorn S, Sukapirom K, Senawong S, et al.
Asian Pac J Allergy Immunol
. 2023 Jul;
42(3):276-289.
PMID: 37466962
Background: The appropriate COVID-19 booster vaccine following inactivated or adenoviral vector COVID-19 vaccination is unclear. Objective: To investigate the immunogenicity of four COVID-19 booster vaccines. Methods: We prospectively enrolled healthy...
8.
Tancharoen L, Muangsomboon S, Sarasombath P, Angkasekwinai N
BMC Infect Dis
. 2023 Mar;
23(1):185.
PMID: 36991362
Background: Pneumocystis jirovecii infection is the most common opportunistic infection that causes pneumonia in human immunodeficiency virus (HIV)-infected patients; however, extrapulmonary P. jirovecii infection is extremely rare after the use...
9.
Angkasekwinai N, Prawjaeng J, Leelahavarong P, Khuntha S, Pheerapanyawaranun C, Chitpim N, et al.
Asian Pac J Allergy Immunol
. 2023 Jan;
40(4):321-336.
PMID: 36681658
Background: The data on the immunogenicity and efficacy of heterologous primary series COVID-19 vaccination are still limited. Objective: To investigate the immunogenicity and vaccine efficacy/effectiveness compared between heterologous and homologous...
10.
Sirijatuphat R, Sirianan K, Horthongkham N, Komoltri C, Angkasekwinai N
Trop Med Infect Dis
. 2023 Jan;
8(1).
PMID: 36668968
This study aimed to determine distinguishing predictors and develop a clinical score to differentiate COVID-19 and common viral infections (influenza, respiratory syncytial virus (RSV), dengue, chikungunya (CKV), and zika (ZKV))....